Condition
Siewert Type II Adenocarcinoma of Esophagogastric Junction clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Siewert Type II Adenocarcinoma of Esophagogastric Junction clinical trials that are recruiting, at sites in 3 countries (most in China (2), United States (1), Russia (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Siewert Type II Adenocarcinoma of Esophagogastric Junction clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Immediate and functional outcomes after different reconstructions following proximal stomach removal | — | Moscow | Recruiting | Mar 2, 2026 |
| Comparing right and left thoracic surgical methods for treating a specific type of esophageal cancer | — | Beijing | Recruiting | Oct 16, 2024 |
| Using Vactosertib with Chemoradiotherapy for Esophageal Adenocarcinoma | Phase 2 | Cleveland, Ohio | Recruiting | Sep 21, 2023 |
| Comparing surgical methods for Siewert Type II adenocarcinoma at the esophagogastric junction | — | Xi'an, Shaanxi | Recruiting | May 2, 2022 |
All recruiting trials (4)
-
Immediate and functional outcomes after different reconstructions following proximal stomach removal
This project will compare different ways of reconnecting the digestive tract after proximal gastrectomy to see which approach leads to better function and quality of life for people having surgery for cancers at the top of the stomach or the esophagogastric junction.
-
Comparing right and left thoracic surgical methods for treating a specific type of esophageal cancer
This study is testing whether surgery on the right or left side of the chest works better for people with a specific type of esophageal cancer after they've had chemotherapy.
-
Using Vactosertib with Chemoradiotherapy for Esophageal Adenocarcinoma
This study is testing if adding a new drug called vactosertib to standard treatment can help people with localized esophageal adenocarcinoma have better results and lower chances of cancer coming back after surgery.
-
Comparing surgical methods for Siewert Type II adenocarcinoma at the esophagogastric junction
This study is testing two different surgical methods to see which one works better and is safer for people with Siewert Type II adenocarcinoma at the esophagogastric junction.
Related topics
Quick answers
How many Siewert Type II Adenocarcinoma of Esophagogastric Junction clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), United States (1 trial), Russia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.